Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

January 2011; Volume 31,Issue 1

Experimental Studies

  • You have access
    Inhibition of Tumor Cellular Proteasome Activity by Triptolide Extracted from the Chinese Medicinal Plant ‘Thunder God Vine’
    LI LU, JYOTI KANWAR, SARA SCHMITT, QIUZHI CINDY CUI, CHUANYIN ZHANG, CONG ZHAO and Q. PING DOU
    Anticancer Research January 2011, 31 (1) 1-10;
  • You have access
    Frequent Absence of Tumor Suppressor FUS1 Protein Expression in Human Bone and Soft Tissue Sarcomas
    GUIDONG LI, HIROYUKI KAWASHIMA, LIN JI, AKIRA OGOSE, TAKASHI ARIIZUMI, HAJIME UMEZU, YONGJUN XU, TETSUO HOTTA and NAOTO ENDO
    Anticancer Research January 2011, 31 (1) 11-21;
  • You have access
    Measuring IGF-1, ER-α and EGFR Expression Can Predict Tamoxifen-resistance in ER-positive Breast Cancer
    KELVIN CHONG, ASHOK SUBRAMANIAN, ANUP SHARMA and KEFAH MOKBEL
    Anticancer Research January 2011, 31 (1) 23-32;
  • You have access
    Human Lymphoma Cells Develop Resistance to Radiation in the Presence of Astrocytes In Vitro
    MASASHI KOTO, HEUNGLAE CHO, OLIVER RIESTERER, UMA GIRI, MICHAEL D. STORY, CHUL S. HA and UMA RAJU
    Anticancer Research January 2011, 31 (1) 33-38;
  • You have access
    Apoptosis of SAS Cells Induced by Sonodynamic Therapy Using 5-Aminolevulinic Acid Sonosensitizer
    WEI SONG, HAIDONG CUI, RUI ZHANG, JINHUA ZHENG and WENWU CAO
    Anticancer Research January 2011, 31 (1) 39-45;
  • You have access
    Procathepsin D and Cytokines Influence the Proliferation of Lung Cancer Cells
    VACLAV VETVICKA and JANA VETVICKOVA
    Anticancer Research January 2011, 31 (1) 47-51;
  • You have access
    Feulgen Staining Remains the Gold Standard for Precise DNA Image Cytometry
    STEFAN BIESTERFELD, SASCHA BECKERS, MARIA DEL CARMEN VILLA CADENAS and MARTIN SCHRAMM
    Anticancer Research January 2011, 31 (1) 53-58;
  • You have access
    EGFR Codon 497 Polymorphism – Implications for Receptor Sensitivity to Inhibitors in HNSCC Cell Lines
    VANESSA KROHN, SUSANNE WIEGAND, JOCHEN A. WERNER and ROBERT MANDIC
    Anticancer Research January 2011, 31 (1) 59-65;
  • You have access
    Overexpression of Interleukin-6 Suppresses Cisplatin-induced Cytotoxicity in Esophageal Squamous Cell Carcinoma Cells
    KENTARO SUCHI, HITOSHI FUJIWARA, SHINICHI OKAMURA, HIROKO OKAMURA, SEIJI UMEHARA, MOMOKO TODO, AKINOBU FURUTANI, MASAYUKI YONEDA, ATSUSHI SHIOZAKI, TAKESHI KUBOTA, DAISUKE ICHIKAWA, KAZUMA OKAMOTO and EIGO OTSUJI
    Anticancer Research January 2011, 31 (1) 67-75;
  • You have access
    TIP60 as a Potential Marker for the Malignancy of Gastric Cancer
    KAZUMA SAKURABA, KAZUAKI YOKOMIZO, ATSUSHI SHIRAHATA, TETSUHIRO GOTO, MITSUO SAITO, KAZUYOSHI ISHIBASHI, GAKU KIGAWA, HIROSHI NEMOTO and KENJI HIBI
    Anticancer Research January 2011, 31 (1) 77-79;
  • You have access
    Cytotoxicity of Thymus vulgaris Essential Oil Towards Human Oral Cavity Squamous Cell Carcinoma
    SERKAN SERTEL, TOLGA EICHHORN, PETER K. PLINKERT and THOMAS EFFERTH
    Anticancer Research January 2011, 31 (1) 81-87;
  • You have access
    Thyroid Hormones (T3 and T4): Dual Effect on Human Cancer Cell Proliferation
    GIULIA MORIGGI, CECILIA VERGA FALZACAPPA, CLAUDIA MANGIALARDO, SIMONA MICHIENZI, ANTONIO STIGLIANO, ERCOLE BRUNETTI, VINCENZO TOSCANO and SILVIA MISITI
    Anticancer Research January 2011, 31 (1) 89-96;
  • You have access
    Prognostic Value of Mitotic Counts in Breast Cancer of Saudi Arabian Patients
    ABDELBASET BUHMEIDA, JAUDAH AL-MAGHRABI, ADNAN MERDAD, FATIMA AL-THUBAITY, ADEEL CHAUDHARY, MAMDOOH GARI, ADEL ABUZENADAH, YRJÖ COLLAN, KARI SYRJÄNEN and MOHAMMED AL-QAHTANI
    Anticancer Research January 2011, 31 (1) 97-103;
  • You have access
    NK4 Gene Therapy Combined with Cisplatin Inhibits Tumour Growth and Metastasis of Squamous Cell Carcinoma
    GOICHI MATSUMOTO, YASUSHI OMI, USHAKU LEE, EIRO KUBOTA and YASUHIKO TABATA
    Anticancer Research January 2011, 31 (1) 105-111;
  • You have access
    Constitutively Active FGFR3 with Lys650Glu Mutation Enhances Bortezomib Sensitivity in Plasma Cell Malignancy
    MASAYASU OTSUKA, MASAO MIZUKI, JIRO FUJITA, SUMIN KANG and YUZURU KANAKURA
    Anticancer Research January 2011, 31 (1) 113-122;
  • You have access
    The Tumor Suppressive Effect of Angiotensin II Type 1 Receptor Antagonist in a Murine Osteosarcoma Model
    JUNJI WASA, HIDESHI SUGIURA, EIJI KOZAWA, KEISHI KOHYAMA, KENJI YAMADA and OSAMU TAGUCHI
    Anticancer Research January 2011, 31 (1) 123-127;
  • You have access
    New Sarcomatoid Cancer Cell Line SAR-HCV Established from a Hepatitis C Virus-related Liver Tumour Lesion
    DAR-IN TAI, YA-JU SHEN, WEN-HUI WENG, HUI-WEN CHEN, CHEN-CHEN KANG, TSE-CHING CHEN and SHUEN-KUEI LIAO
    Anticancer Research January 2011, 31 (1) 129-137;
  • You have access
    Oncogramme, A New Promising Method for Individualized Breast Tumour Response Testing for Cancer Treatment
    S. GIRAUD, E. LOUM, B. BESSETTE, V. FERMEAUX and C. LAUTRETTE
    Anticancer Research January 2011, 31 (1) 139-145;
  • You have access
    Hepatic Arterial Infusion in the Treatment of Liver Metastases with PEG Liposomes in Combination with Degradable Starch Microspheres (DSM) Increases Tumor 5-FU Concentration. An Animal Study in CC-531 Liver Tumor-bearing Rats
    U. POHLEN, R. RESZKA, H.J. BUHR and G. BERGER
    Anticancer Research January 2011, 31 (1) 147-152;
  • You have access
    Improvement of Biodistribution with PEGylated Liposomes Containing Docetaxel with Degradable Starch Microspheres for Hepatic Arterial Infusion in the Treatment of Liver Metastases: A Study in CC-531 Liver Tumor-bearing WAG RIJ Rats
    U. POHLEN, H.J. BUHR and G. BERGER
    Anticancer Research January 2011, 31 (1) 153-159;
  • You have access
    Neem Leaf Extract Induces Radiosensitization in Human Neuroblastoma Xenograft Through Modulation of Apoptotic Pathway
    JAMUNARANI VEERARAGHAVAN, SHEEJA ARAVINDAN, MOHAN NATARAJAN, VIBHUDUTTA AWASTHI, TERENCE S HERMAN and NATARAJAN ARAVINDAN
    Anticancer Research January 2011, 31 (1) 161-170;
  • You have access
    MAGE Expressions Mediated by Demethylation of MAGE Promoters Induce Progression of Non-small Cell Lung Cancer
    NAOKI YANAGAWA, GEN TAMURA, HIROYUKI OIZUMI, MAKOTO ENDOH and TEIICHI MOTOYAMA
    Anticancer Research January 2011, 31 (1) 171-175;
  • You have access
    Oleic Acid Is the Active Component in the Mushroom Daedalea gibbosa Inhibiting Bcr-Abl Kinase Autophosphorylation Activity
    HAZEM KHAMAISIE, SHERBEL SUSSAN, MICHAEL TAL, YOUSEF NAJAJREH, MARTIN RUTHARDT and JAMAL MAHAJNA
    Anticancer Research January 2011, 31 (1) 177-183;
  • You have access
    Chemical Composition and Antiproliferative Activity of Essential Oil from the Leaves of a Medicinal Herb, Levisticum officinale, against UMSCC1 Head and Neck Squamous Carcinoma Cells
    SERKAN SERTEL, TOLGA EICHHORN, PETER K. PLINKERT and THOMAS EFFERTH
    Anticancer Research January 2011, 31 (1) 185-191;
  • You have access
    Anticancer and Antimetastatic Activities of Renieramycin M, a Marine Tetrahydroisoquinoline Alkaloid, in Human Non-small Cell Lung Cancer Cells
    HASSERI HALIM, PREEDAKORN CHUNHACHA, KHANIT SUWANBORIRUX and PITHI CHANVORACHOTE
    Anticancer Research January 2011, 31 (1) 193-201;
  • You have access
    ATM/ATR and SMAD3 Pathways Contribute to 3-Indole-induced G1 Arrest in Cancer Cells and Xenograft Models
    SIN-MING HUANG, KWOK-TUNG LU and YI-CHING WANG
    Anticancer Research January 2011, 31 (1) 203-208;
  • You have access
    Effect of Genistein on p90RSK Phosphorylation and Cell Proliferation in T47D Breast Cancer Cells
    JOHN GWIN, NEIL DREWS, SYED ALI, JUSTIN STAMSCHROR, MATTHEW SORENSON and TALITHA T. RAJAH
    Anticancer Research January 2011, 31 (1) 209-214;
  • You have access
    Increased Efficacy and Reduced Cardiotoxicity of Metronomic Treatment with Cyclophosphamide in Rat Breast Cancer
    VALENTINA K. TODOROVA, YIHONG KAUFMANN and V. SUZANNE KLIMBERG
    Anticancer Research January 2011, 31 (1) 215-220;
  • You have access
    Association of Cyclooxygenase 2 Polymorphic Genotypes with Prostate Cancer in Taiwan
    HSI-CHIN WU, CHAO-HSIANG CHANG, HUNG-LUNG KE, WEN-SHIN CHANG, HUI-NI CHENG, HUI-HUI LIN, CHI-YU WU, CHIA-WEN TSAI, RU-YIN TSAI, WOEI-CHUNG LO and DA-TIAN BAU
    Anticancer Research January 2011, 31 (1) 221-225;
  • You have access
    Significant Association of Cyclin D1 Single Nucleotide Polymorphisms with Oral Cancer in Taiwan
    MING-HSUI TSAI, CHIA-WEN TSAI, YUNG-AN TSOU, CHUN-HUNG HUA, CHIA-FANG HSU and DA-TIAN BAU
    Anticancer Research January 2011, 31 (1) 227-231;
  • You have access
    Ruta graveolens Extract Induces DNA Damage Pathways and Blocks Akt Activation to Inhibit Cancer Cell Proliferation and Survival
    KHALDA FADLALLA, ANGELA WATSON, TESHOME YEHUALAESHET, TIMOTHY TURNER and TEMESGEN SAMUEL
    Anticancer Research January 2011, 31 (1) 233-241;

Clinical Studies

  • You have access
    Detection and Significance of Parametrial Micrometastases in Early-stage Cervical Cancer
    PAULA C. BRADY, XIAOWEI CHEN, WILLIAM M. BURKE, ISRAEL DEUTSCH, XUMING SUN, THOMAS J. HERZOG and JASON D. WRIGHT
    Anticancer Research January 2011, 31 (1) 243-247;
  • You have access
    Phase II Study of Saracatinib (AZD0530) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
    MATTHEW G. FURY, SHRUJAL BAXI, RONGLAI SHEN, KATHERINE W. KELLY, BRYNNA L. LIPSON, DIANE CARLSON, HILDA STAMBUK, SOFIA HAQUE and DAVID G. PFISTER
    Anticancer Research January 2011, 31 (1) 249-253;
  • You have access
    A Phase II Study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal Cancer
    NAN SOON WONG, NISHAN H. FERNANDO, ANDREW B. NIXON, STEPHANIE CUSHMAN, MEBEA AKLILU, JOHANNA C. BENDELL, MICHAEL A. MORSE, GERARD C. BLOBE, JILL ASHTON, HERBERT PANG and HERBERT I. HURWITZ
    Anticancer Research January 2011, 31 (1) 255-261;
  • You have access
    Expression of LGR5, an Intestinal Stem Cell Marker, During Each Stage of Colorectal Tumorigenesis
    KAYOKO TAKEDA, ICHIRO KINOSHITA, YASUSHI SHIMIZU, YOSHIHIRO MATSUNO, TOSHIAKI SHICHINOHE and HIROTOSHI DOSAKA-AKITA
    Anticancer Research January 2011, 31 (1) 263-270;
  • You have access
    The Role of Pelvic Lymph Node Dissection During Radical Cystectomy for Bladder Cancer
    EUGENIO BRUNOCILLA, REMIGIO PERNETTI and GIUSEPPE MARTORANA
    Anticancer Research January 2011, 31 (1) 271-275;
  • You have access
    Two Cases with a Long-term Survival Following Multidisciplinary Treatment for Recurrent Breast Cancer After Surgery
    HIDETAKA URAMOTO and TAKESHI HANAGIRI
    Anticancer Research January 2011, 31 (1) 277-279;
  • You have access
    C-erbB-3 Expression in Non-small Cell Lung Cancer (NSCLC) Patients Treated by Erlotinib
    INGRID CsTOTH, GÉRALDINE ANTHOINE, THIERRY BERGHMANS, CÉLINE MASCAUX, MARIANNE PAESMANS, JEAN-PAUL SCULIER and ANNE-PASCALE MEERT
    Anticancer Research January 2011, 31 (1) 281-285;
  • You have access
    A Phase II Study of Weekly Paclitaxel and Doxifluridine Combination Chemotherapy for Advanced/Recurrent Gastric Cancer
    IZUMI TAKEYOSHI, FUJIO MAKITA, YOSHIFUMI TANAHASHI, SHIGERU IWAZAKI, TETSUSHI OGAWA, NAOKI TOMIZAWA, SEIJI NAKAMURA, HITOSHI ISHIKAWA, TOSHIHIRO OHYA, SHINICHI KAKINUMA, KATSUNAO NAKAGAMI, YOSHIHIRO SATO, TETSUYA KOYANO, TAKASHI ROPPONGI, MASARU IZUMI, JUNYA KOBAYASHI, SUSUMU KAWATE, YUTAKA SUNOSE, MITSUNOBU KOBAYASHI, TATSUYA YAMADA and ICHIRO SAKAMOTO
    Anticancer Research January 2011, 31 (1) 287-291;
  • You have access
    Cortactin in Breast Cancer: Analysis with Tissue Microarray
    SHYR-MING SHEEN-CHEN, CHUN-YING HUANG, YU-YIN LIU, CHAO-CHENG HUANG and REI-PING TANG
    Anticancer Research January 2011, 31 (1) 293-297;
  • You have access
    Successful S-1 Monotherapy for Chemorefractory Thymic Carcinoma
    TOMONOBU KOIZUMI, TOSHIHIKO AGATSUMA, YOSHIMICHI KOMATSU and KEISHI KUBO
    Anticancer Research January 2011, 31 (1) 299-301;
  • You have access
    Prognostic Value of the Human Antigen R (HuR) in Human Breast Cancer: High Level Predicts a Favourable Prognosis
    ZHU YUAN, ANDREW J. SANDERS, LIN YE, YU WANG and WEN G. JIANG
    Anticancer Research January 2011, 31 (1) 303-310;
  • You have access
    Pronounced Tumour Regression after Radiotherapy is Associated with Negative/Weak Glucose Transporter-1 Expression in Rectal Cancer
    E. KORKEILA, P.M. JAAKKOLA, K. SYRJÄNEN, S. PYRHÖNEN and J. SUNDSTRÖM
    Anticancer Research January 2011, 31 (1) 311-315;
  • You have access
    Randomized Phase II Study of Paclitaxel and Carboplatin or Vinorelbine in Advanced Non-small Cell Lung Cancer
    KRISTOPH JAHNKE, ULRICH KEILHOLZ, DIANA LÜFTNER, ECKHARD THIEL and ALEXANDER SCHMITTEL
    Anticancer Research January 2011, 31 (1) 317-323;
  • You have access
    Clinical Significance of STC1 Gene Expression in Patients with Colorectal Cancer
    SHUZO TAMURA, TAKASHI OSHIMA, KAZUE YOSHIHARA, AMANE KANAZAWA, TAKANOBU YAMADA, DAISUKE INAGAKI, TSUTOMU SATO, NAOTO YAMAMOTO, MANABU SHIOZAWA, SOICHIRO MORINAGA, MAKOTO AKAIKE, CHIKARA KUNISAKI, KATSUAKI TANAKA, MUNETAKA MASUDA and TOSHIO IMADA
    Anticancer Research January 2011, 31 (1) 325-329;
  • You have access
    Temsirolimus in Metastatic Chromophobe Renal Cell Carcinoma after Interferon and Sorafenib Therapy
    BERNARD PAULE and NATHALIE BRION
    Anticancer Research January 2011, 31 (1) 331-333;
  • You have access
    5-FU-induced Hyperammonemic Encephalopathy in a Case of Metastatic Rectal Adenocarcinoid Successfully Rechallenged with the Fluoropyrimidine Analog, Capecitabine
    POOJA P. ADVANI and MARWAN G. FAKIH
    Anticancer Research January 2011, 31 (1) 335-338;
  • You have access
    Predictive Value of Serum Biomarkers in Patients After Portal Vein Embolization (PVE): A Pilot Study
    VLADISLAV TRESKA, ONDREJ TOPOLCAN, JINDRA VRZALOVA, TOMAS SKALICKY, ALAN SUTNAR, VACLAV LISKA, JAKUB FICHTL, ANDREA NARSANSKA, JIRI FERDA, INKA TRESKOVA, HYNE MIRKA and BORIS KREUZBERG
    Anticancer Research January 2011, 31 (1) 339-344;
  • You have access
    The Dynamics of Serum Tumor Markers in Predicting Metastatic Uveal Melanoma (Part 1)
    VIVIAN BARAK, IGOR KAISERMAN, SHAHAR FRENKEL, KEREN HENDLER, INNA KALICKMAN and JACOB PE'ER
    Anticancer Research January 2011, 31 (1) 345-349;
  • You have access
    Trends in Liver Function Tests: A Comparison with Serum Tumor Markers in Metastatic Uveal Melanoma (Part 2)
    KAREN HENDLER, JACOB PE'ER, IGOR KAISERMAN, RONEN BARUCH, INNA KALICKMAN, VIVIAN BARAK and SHAHAR FRENKEL
    Anticancer Research January 2011, 31 (1) 351-357;
  • You have access
    Pharmacogenetic Tailoring of Irinotecan-based First-line Chemotherapy in Metastatic Colorectal Cancer: Results of a Pilot Study
    GILLES FREYER, AUDE DURET, GERARD MILANO, ETIENNE CHATELUT, CHRISTINE REBISCHUNG, JEAN-PIERRE DELORD, YACINE MERROUCHE, GERARD LLEDO, MARIE-CHRISTINE ETIENNE and CLAIRE FALANDRY
    Anticancer Research January 2011, 31 (1) 359-366;
  • You have access
    Risk of Ipsilateral Breast Tumor Recurrence in Patients Treated with Tamoxifen or Anastrozole Following Breast-conserving Surgery with or without Radiotherapy
    MAKOTO ISHITOBI, SAKI NAKAHARA, YOSHIFUMI KOMOIKE, KAZUYOSHI MOTOMURA, HIROKI KOYAMA and HIDEO INAJI
    Anticancer Research January 2011, 31 (1) 367-371;
  • You have access
    Parameters of Biological Activity in Colorectal Cancer
    SARKA SVOBODOVA, ONDREJ TOPOLCAN, LUBOS HOLUBEC, MIROSLAV LEVY, LADISLAV PECEN and STEPAN SVACINA
    Anticancer Research January 2011, 31 (1) 373-378;
Back to top
PreviousNext

In this issue

Anticancer Research: 31 (1)
Anticancer Research
Vol. 31, Issue 1
January 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Experimental Studies
  • Clinical Studies
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire